Results 241 to 250 of about 396,771 (306)

Beyond BMI: The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States

Obesity, EarlyView.
ABSTRACT Objective This study compared population characteristics and overall US prevalence of obesity over time using the BMI criteria and the 2025 Lancet Commission criteria (i.e., the Excess Adiposity criteria). Methods We analyzed data from 58,053 adults aged ≥ 20 years in the National Health and Nutrition Examination Survey from 1999 to 2023.
Jennifer H. Hwang, Neda Laiteerapong
wiley   +1 more source

Traditional and Emerging Lipid Markers for Cardiovascular Risk Assessment in Young vs Older Adults.

JAMA Netw Open
Tang R, An J, Bellows BK, Moran AE, Allen NB, Wilkins JT, Xanthakis V, Tsai MY, Shah NS, Reynolds K, Zhang Y.   +10 more
europepmc   +1 more source

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients. [PDF]

J Lipid Res
Jang Y, Kim BJ, Jeong YW, Kang DR, Koh KK, Nordestgaard BG, Han SH.   +6 more
europepmc   +1 more source

Retatrutide Shows Multiple Metabolic Benefits in Diet‐Induced Obese MASH Mouse and Hamster Models

Obesity, EarlyView.
ABSTRACT Objective/Methods Our aim was to evaluate the efficacy of the triple glucagon, GIP, and GLP‐1 receptor agonist retatrutide in diet‐induced obese MASH mouse and hamster models, two preclinical models that we routinely use for assessing new therapies targeting obesity.
François Briand, Camille Le Cudennec, Estelle Grasset, Natalia Breyner, Claire Bigot, Pierre Dillard, Thierry Sulpice   +6 more
wiley   +1 more source

The High Burden of Dyslipidemia in Ibb, Yemen: A Retrospective Analysis From 2018 to 2026 of Gender and Age Associations in 14,691 Individuals. [PDF]

Cureus
Al-Hetar MAMY, Wahab NA, Al-Shawky S, Al-Matary AM, Senan DAM, Alezzy M, Al-Hetar MM, Asaber AM.   +7 more
europepmc   +1 more source

Adropin: An endocrine link between the biological clock and cholesterol homeostasis [PDF]

, 2018
et al,, Rao, D. C
core   +1 more source

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

Obesity, EarlyView.
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak, Arshdeep Rattol, Eduardo Grunvald   +2 more
wiley   +1 more source

Causal effect of obesity on cataract and mediating roles of metabolites: a Mendelian randomization study. [PDF]

Int J Ophthalmol
Li C, Wang JM, Yang WH.
europepmc   +1 more source

Stratification of Pro-Atherogenic Phenotypes in Prediabetes Using Machine Learning. [PDF]

Biomedicines
Signorini L, Volanski W, Prado ALD, Valdameri G, Anghebem MI, Moure VR, Sari MHM, Picheth G, Rego FGM.   +8 more
europepmc   +1 more source

Association of Blood Arsenic Concentrations with Lipid Markers in Uruguayan Adolescents: Exploring Effect Modification by Body Mass Index and Sex. [PDF]

Expo Health
Desai G, Queirolo EI, Quattrin T, Parsons PJ, Palmer CD, Beledo MI, Kordas K.   +6 more
europepmc   +1 more source